重组Anti-NF2 / Merlin抗体[EPR2573(2)]
Anti-NF2 / Merlin antibody [EPR2573(2)]
- RabMAb
- Recombinant
- KO Validated
- 了解详情
Be the first to review this product! Submit a review
|
(13 Publications)
Knockout Tested Rabbit Recombinant Monoclonal NF2 / Merlin antibody. Suitable for WB and reacts with Human, Mouse samples. Cited in 13 publications.
查看别名
SCH, NF2, Merlin, Moesin-ezrin-radixin-like protein, Neurofibromin-2, Schwannomerlin, Schwannomin
- WB
Unknown
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (AB109244)
All lanes:
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (ab109244) at 1/50000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
MCF7 cell lysate at 10 µg
Lane 3:
Jurkat cell lysate at 10 µg
Lane 4:
PC3 cell lysate at 10 µg
Predicted band size: 70 kDa
false
- WB
Lab
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (AB109244)
False colour image of Western blot : Anti-NF2 / Merlin antibody [EPR2573(2)] staining at 1/50000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab109244 was shown to bind specifically to NF2 / Merlin. A band was observed at 74 kDa in wild-type HepG2 cell lysates with no signal observed at this size in NF2 knockout cell line ab277859 (knockout cell lysate ab283826). To generate this image, wild-type and NF2 knockout HepG2 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3% milk in TBS-0.1% Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) at 1/20000 dilution.
All lanes:
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (ab109244) at 1/50000 dilution
Lane 1:
Wild-type HepG2 cell lysate at 20 µg
Lane 2:
NF2 knockout HepG2 cell lysate at 20 µg
Lane 2:
Western blot - Human NF2 (Merlin) knockout Hep G2 cell line (<a href='/products/cell-lines/human-nf2-merlin-knockout-hep-g2-cell-line-ab277859'>ab277859</a>)
Predicted band size: 70 kDa
Observed band size: 74 kDa
false
- WB
Lab
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (AB109244)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : NF2 / Merlin knockout HAP1 cell lysate (20 μg)
Lane 3 : MCF7 cell lysate (20 μg)
Lane 4 : Jurkat cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab109244 observed at 70 kDa. Red - loading control, ab8245, observed at 37 kDa.
ab109244 was shown to specifically react with NF2 / Merlin when NF2 / Merlin knockout samples were used. Wild-type and NF2 / Merlin knockout samples were subjected to SDS-PAGE. ab109244 and ab8245 (loading control to GAPDH) were diluted to 1/50000 and 1/10000 respectively and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (ab109244)
Predicted band size: 70 kDa
false
- WB
Lab
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (AB109244)
Lanes 1 - 2 : Merged signal (red and green). Green - ab109244 observed at 60 kDa. Red - loading control ab8245 (Mouse anti-GAPDH antibody [6C5]) observed at 37kDa.
ab109244 was shown to react with NF2 in wild-type HeLa cells in western blot with loss of signal observed in NF2 knockout cell line ab261796 (NF2 knockout cell lysate ab257179). Wild-type and NF2 knockout HeLa cell lysates were subjected to SDS-PAGE. Membranes were blocked in 3% milk in TBS-T (0.1% Tween®) before incubation with ab109244 and ab8245 (Mouse anti-GAPDH antibody [6C5]) overnight at 4°C at a 1 in 1000 dilution and a 1 in 20000 dilution respectively. Blots were incubated with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preabsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preabsorbed (ab216776) secondary antibodies at 1 in 20000 dilution for 1 hour at room temperature before imaging.
All lanes:
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (ab109244) at 1/1000 dilution
Lane 1:
Wild-type HeLa cell lysate at 20 µg
Lane 2:
NF2 knockout HeLa cell lysate at 20 µg
Lane 2:
Western blot - Human NF2 (Merlin) knockout HeLa cell line (<a href='/products/cell-lines/human-nf2-merlin-knockout-hela-cell-line-ab261796'>ab261796</a>)
Predicted band size: 70 kDa
Observed band size: 60 kDa
false
- WB
Supplier Data
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (AB109244)
False colour image of Western blot : Anti-NF2 / Merlin antibody [EPR2573(2)] staining at 1/50000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab109244 was shown to bind specifically to NF2 / Merlin. A band was observed at 73 kDa in wild-type A549 cell lysates with no signal observed at this size in NF2 knockout cell line. To generate this image, wild-type and NF2 knockout A549 cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 3 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-NF2 / Merlin antibody [EPR2573(2)] (ab109244) at 1/50000 dilution
Lane 1:
Wild-type A549 cell lysate at 20 µg
Lane 2:
NF2 knockout A549 cell lysate at 20 µg
Lane 3:
SH-SY5Y cell lysate at 20 µg
Predicted band size: 70 kDa
Observed band size: 73 kDa
false
不同偶联物与剂型 (1)
-
Anti-NF2 / Merlin antibody [EPR2573(2)] - BSA and Azide free
反应性数据
产品详情
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
性能和储存信息
形式
纯化工艺
存储溶液
运输条件
推荐的短期储存条件
推荐的长期储存条件
储存信息
补充信息
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
The NF2 protein functions to control cell proliferation differentiation and motility. It associates with the cytoskeleton acting as a bridge between cell surface proteins and the actin cytoskeleton. Merlin as part of the ERM (ezrin radixin moesin) family contributes to the assembly of protein complexes at the cell membrane. Through its interactions it plays a significant role in maintaining proper cell signaling and structural integrity.
Pathways
NF2 protein integrates into the Hippo signaling pathway which regulates organ size by controlling cell growth and apoptosis. Within this pathway Merlin interacts with members such as YAP1 and LATS1/2 moderating their activity to prevent over-proliferation of cells. NF2 also connects with the mTOR pathway which is critical for cell metabolism and growth further emphasizing its regulatory functions in cellular homeostasis.
产品实验方案
- Visit the General protocols
- Visit the Troubleshooting
靶点信息
文献 (13)
Recent publications for all applications. Explore the full list and refine your search
Nature communications 16:4128 PubMed40319089
2025
Applications
Unspecified application
Species
Unspecified reactive species
Communications biology 7:266 PubMed38438584
2024
Applications
Unspecified application
Species
Unspecified reactive species
Mechanobiology in medicine 1:100023 PubMed40395635
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37345150
2023
Applications
Unspecified application
Species
Unspecified reactive species
Cells 12: PubMed37174657
2023
Applications
Unspecified application
Species
Unspecified reactive species
iScience 25:105275 PubMed36300003
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular medicine 50: PubMed35674159
2022
Applications
Unspecified application
Species
Unspecified reactive species
Cell death & disease 13:71 PubMed35064101
2022
Applications
Unspecified application
Species
Unspecified reactive species
Nature communications 12:4789 PubMed34373451
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of clinical and experimental 11:5705-5714 PubMed31949656
2018
Applications
Unspecified application
Species
Unspecified reactive species
Abcam Product Promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com